PLSE
PULSE BIOSCIENCES, INC.
Key Financials
Operating Income
$-76939000
↓ 36.8%
Revenue
$350000
↑ Infinity%
Net Income
$-72781000
↓ 35.8%
EPS (Diluted)
$-1.50
N/A
Total Liabilities
$13.9M
↓ 21.1%
Total Assets
$94.5M
↓ 28.6%
Shareholders' Equity
$80.7M
↓ 29.8%
Cash & Equivalents
$80.7M
↓ 31.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/6/2026 | View on SEC |
| 424B5 | 8/6/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PLSE |
| Company Name | PULSE BIOSCIENCES, INC. |
| CIK | 1625101 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 510-906-4600 |